Ambrisentan: a review of its use in pulmonary arterial hypertension

by Belinda N. Rivera-Lebron, Michael G. Risbano
Published 2017-06-01

Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility

by William D. Wallace, Mehdi Nouraie, Stephen Y. Chan, Michael G. Risbano
Published 2018-07-01

Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea

by Richard H. Zou, William D. Wallace, S. Mehdi Nouraie, Stephen Y. Chan, Michael G. Risbano
Published 2020-02-01

Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension

by James C. Coons, Cheryl Bunner, David C. Ishizawar, Michael G. Risbano, Belinda Rivera-Lebron, Michael A. Mathier, Stephen Y. Chan, Marc A. Simon
Published 2017-11-01

Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension

by Leonard E. Estephan, Michael V. Genuardi, Chad M. Kosanovich, Michael G. Risbano, Yingze Zhang, Nancy Petro, Annie Watson, Yassmin Al Aaraj, John C. Sembrat, Mauricio Rojas, Dmitry A. Goncharov, Marc A. Simon, Elena A. Goncharova, Anjali Vaidya, Akaya Smith, Jeremy Mazurek, Yuchi Han, Stephen Y. Chan
Published 2019-03-01